0.00

100.00% -3.87

After Hours: 3.87 3.87 +

Plus Therapeutics Inc (PSTV)

Overview News Price History Financials Discussions Forecast Stock Split

Plus Therapeutics Inc stock is traded at $0.00, with a volume of 0. It is down -100.00% in the last 24 hours and down -100.00% over the past month. Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, commercializing and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

Previous Close:

$3.87

Open:

24h Volume:

Relative Volume:

0.00

Market Cap:

$25.68M

Revenue:

$5.21M

Net Income/Loss:

$-26.35M

P/E Ratio:

0.00

EPS:

-32.0862

Net Cash Flow:

$-20.84M

1W Performance:

-100.00%

1M Performance:

-100.00%

6M Performance:

-100.00%

1Y Performance:

-100.00%

1-Day Range:

$0.00

1-Week Range:

$0.00

52-Week Range:

$0.00

$8.00

Plus Therapeutics Inc Stock (PSTV) Company Profile

Name

Plus Therapeutics Inc

Sector

Healthcare (1080)

Industry

Biotechnology (604)

Phone

737.255.7194

Address

4200 MARATHON BLVD., AUSTIN, TX

Employee

Twitter

@plustxinc

Next Earnings Date

2026-08-13

Latest SEC Filings

PSTV's Discussions on Twitter

Compare PSTV vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PSTV Plus Therapeutics Inc	0.00	25.68M	5.21M	-26.35M	-20.84M	-32.09
VRTX Vertex Pharmaceuticals Inc	548.05	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	834.04	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,039.78	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.13	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	209.46	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Plus Therapeutics Inc Stock (PSTV) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-03-26	Initiated	Lake Street	Buy
Sep-03-25	Upgrade	D. Boral Capital	Hold → Buy
Mar-17-25	Initiated	D. Boral Capital	Buy
Jan-25-21	Initiated	Ladenburg Thalmann	Buy
Oct-16-20	Initiated	Maxim Group	Buy

Plus Therapeutics Inc Stock (PSTV) Latest News

Aug 22, 2026

Radiation therapy co. Cerenome plans major expansion at Hines' Levit Green campus - The Business Journals

Aug 20, 2026

Aug 19, 2026

PLUS (PSTV) Range: Trades in a Narrow Directional Range at $3.87 in the Latest Session; Market Levels: the Price Remains Bounded by the Supplied Support and Resistance in the Latest SessionIndex Put Call - Vinanet

Aug 19, 2026

Aug 18, 2026

Plus Therapeutics (CNSY) Stock Trends and Sentiment 2026 - MarketBeat

Aug 18, 2026

Aug 17, 2026

Plus Therapeutics (CNSY) Q2 Earnings Miss Highlight Challenges A - GuruFocus

Aug 17, 2026

Aug 14, 2026

Plus Therapeutics Stock Price Forecast. Should You Buy PSTV? - StockInvest.us

Aug 14, 2026

Plus Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 14, 2026

Cerenome Reports $9.0 Million Second-Quarter 2026 Net Loss - Quiver Quantitative

Aug 14, 2026

Cerenome Reports Second Quarter 2026 Financial Results and Business Update - The Manila Times

Aug 14, 2026

Plus Therapeutics (CNSY) Financials 2026Income Statement and Balance Sheet - MarketBeat

Aug 14, 2026

Aug 13, 2026

Plus Therapeutics (CNSY) Earnings Date and Reports 2026 - MarketBeat

Aug 13, 2026

PSTV Stock On Track For Best Week Since September — Here’s What Is Driving The Rally - Stocktwits

Aug 13, 2026

Aug 12, 2026

Plus Therapeutics (CNSY) Stock Chart and Price History 2026 - MarketBeat

Aug 12, 2026

Aug 10, 2026

Technical Analysis of Cerenome, Inc. (NASDAQ:CNSY) - TradingView

Aug 10, 2026

Plus Therapeutics Inc expected to post a loss of 91 cents a shareEarnings Preview - TradingView

Aug 10, 2026

Aug 07, 2026